Obamacare Should Be Encouraging For Healthcare Division
Tue, 04/03/2012 - 06:48 | 
When President Barack Obama entered into the Patient Protection and Affordable Care Act (PPACA), commonly known as "Obamacare," during March 2010, it received large amounts of extolment and unfavorable judgment. The majority of individuals seem to feel sturdily in one direction or the other.
Scrip of drug manufacturer Aurobindo Pharma saw huge selling pressure after the firm’s MD was named in a chargesheet lodged by the Central Bureau of Investigation (CBI).
Gerresheimer AG, a German supplier of pharma and healthcare products has got hold of 70% equity stake in the Indian bottles manufacturer Neutral Glass & Allied Industries Pvt Ltd for an unrevealed sum.
Tags: Arena Pharma Declines As Analyst Salshes Rating
Shares of Arena Pharmaceuticals declined Wednesday after a Piper Jaffray forecaster demoted the stock, mentioning that the share cost has developed as Wall Street turns more promising that Arena's obesity medication lorcaserin will get sanctioned.
Dr Reddy’s Laboratories, Sun Pharma and Lupin Ltd have received a final nod for their Quetiapine Fumaratac tabs of 25 mg, 50 mg, 100 mg, 200 mg, 300 mg and 400 mg intensities from USFDA.
Maker of generic pharmaceuticals and active pharma components Aurobindo Pharma Ltd. declared that the company had received final authorizations from the USFDA to sell Quetiapine Fumarate tabs 25mg, 50mg, 100mg, 150mg, 200mg, 300mg and 400mg.
Watson Pharma Seeks FDA Nod For Cholesterol Drug Niaspan
Generic drug maker Watson Pharmaceuticals Inc. stated that it is seeking favorable reception from the Food and Drug Administration to sell a generic edition of Abbott Laboratories' cholesterol medication Niaspan.
Stock market analyst Siddharth Bhamre, Angel Broking, has maintained buy rating on Aurobindo Pharma stock with a target of Rs 132.
Mankind Pharma, a large pharmaceutical firm, is making entry in the eye care and skin treatment group and proposes to introduce two novel products in the market shortly.
IT Raids On Aurobindo Pharma; Sun Pharma To Announce Quarterly Results On Feb 13
Aurobindo Pharma Ltd’s scrip dropped 5.67% on the Bombay Stock Exchange (BSE) on February 10 following reports of IT raids and sudden annulment of board conference.
Cambridge based Ironwood Pharmaceuticals has declared that it is offering up 5.3 million Class A scrips to aid toughen its balance sheet.
The ex biz development director of Takeda Pharmaceuticals International made $63,000 in profits from insider trading.
Sun Pharmaceuticals, India’s biggest drug manufacturer by market cap, is ready to declare its outcomes for the three month period ended December FY12 on February 13.
